Efficacy, Immunogenicity, and Safety of the Combined Vector Vaccine Gam-COVID-Vac in Patients with Rheumatic Diseases
The aim of the study is to assess the efficacy, immunogenicity, and safety of the combined vector vaccine Gam-COVID-Vac and to determine the risk factors for the development of adverse events (AEs) in patients with rheumatic diseases (RD).Patients and methods. The present study consisted of a retros...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2024-11-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1161 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|